Snup (xylometazoline) Nasal Spray 15 ml
21515USD

Snup (xylometazoline) Nasal Spray 15 ml

SKU:2519
To favorites
Snup (xylometazoline) Nasal Spray belongs to the group of local vasoconstrictors, causes narrowing of the blood vessels of the nasal mucosa, eliminating swelling and hyperemia of the nasal mucosa, restores the patency of the nasal passages, facilitates nasal breathing
Active substance:xylometazoline
Pharmacological group:Rhinitis medicines
Formulation:Spray
Dosage mg:150
In stock
In stock
$15
11
Description
Features
Reviews

Instructions for Snup (xylometazoline) Nasal Spray 15 ml

English product name
Snup

Release Form
nasal dosed spray 45 μg/1 dose: fl. 15 ml (150 doses) with spray system

Description Snup
Nasal spray dosed in the form of a colorless transparent solution.

1 dose
xylomethazoline hydrochloride 45μg
Auxiliary substances: sea water, potassium dihydrophosphate, purified water.

15 ml (150 doses) - polyethylene bottles (1) with spray system - cardboard packs.

ATC codes
R01AA07 Xylometazoline

Clinical-pharmacological groups / Group affiliation
Vasoconstricting preparation for local use in ENT practice

Active substance
xylomethazoline hydrochloride

Pharmaco-therapeutic group Snup

Anticongestive agent - alpha-adrenomimetic

Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.

Best before date
The shelf life is five years. Do not apply after expiry date.
After opening the bottle, the drug should be used for 12 months.

Pharmacological effect Snup

Xylomethazoline belongs to a group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity. It causes narrowing of blood vessels of the mucous membrane of the nose, eliminating swelling and hyperemia of the mucous membrane of the nose, restores passability of nasal passages, facilitates nasal breathing.
The effect of the preparation occurs in 5-10 minutes after its use and lasts up to

Testimony Snup

  • acute respiratory diseases with rhinitis (runny nose);
  • acute allergic rhinitis;
  • pollinosis;
  • sinusitis;
  • eustachitis;
  • Moderate otitis (in combination therapy to reduce swelling of nasopharyngeal mucosa);
  • preparation of the patient for diagnostic manipulation in the nasal passages.

Method of use, course and dosage Snup

Intranasally.
Snoop® nasal dosed spray 45 μg/dose
Children aged from two to five years 1 injection per nasal stroke 1-3 times/day.
Adults and children from 6 years of age 1-2 injection into each nasal passage 2-3 times/day.
Do not apply more than three times a day.
Snoop® nasal dosed spray 90 μg/dose

  • Nosology Snup (ICD codes)
  • H66
  • Pus and unspecified mean otitis
  • H68
  • Inflammation and blockage of the auditory [eustachian] tube
  • J00
  • Acute nasopharyngitis (runny nose)
  • J01
  • Acute sinusitis
  • J06.9
  • Acute upper respiratory tract infection unspecified
  • J30.1
  • Allergic rhinitis caused by plant pollen
  • J30.3
  • Other allergic rhinitis (year-round allergic rhinitis)
  • J32
  • Chronic sinusitis
  • Z51.4
  • Preparatory procedures for follow-up treatment or examination not classified elsewhere
Features
Active substance
Pharmacological group
Formulation
Dosage mg
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Analogues
Rhinostop (Xylometazoline) spray
SKU:932
$9
In stock
Rhinostop (Xylometazoline) drops
SKU:930
$5
In stock